Projects per year
Search results
-
Active
ANI389: Development of a B7-H3 nanoCAR-T cell therapy for recurrent glioblastoma (GlioCAR)
Neyns, B., Geeraerts, X., Tuyaerts, S., Breckpot, K., Duerinck, J. & Smolders, I.
1/10/24 → 30/09/28
Project: Fundamental
-
ANI352: MOTUNE-T therapy: Metabolically Optimized TUNEd T cells as treatment for recurrent glioblastoma
1/10/23 → 30/09/27
Project: Fundamental
-
ANI27: Therapeutic vaccination of cancer patients with defined tumor antigens recognized by T lymphocytes.
16/01/04 → …
Project: Fundamental
-
Finished
ANI358: Unravelling the anti-tumor effect of autologous myeloid dendritic cel Is plus the synthetic adjuvant AS01B in solid tumors.
1/11/23 → 31/10/24
Project: Fundamental
-
-
OZR3588: Financiering FWO hercules: ERA platform: Extended RNA Analysis platform - version 2.0
Rooman, I., Bouwens, L., Heimberg, H., Neyns, B., Vranken, W., Vanhaecke, T., Massie, A., van Grunsven, L., De Bruyne, E., De Bundel, D., Forsyth, R., Breckpot, K., Van Dooren, S., De Kock, J., Njemini, R. & Laoui, D.
1/05/20 → 30/04/24
Project: Fundamental
-
SRP62: SRP-Groeifinanciering: Single-domain antibody fragment (SdAb)-based TArgeted Radionuclide Therapy: STaRT programme
Keyaerts, M., D'Huyvetter, M. & Neyns, B.
1/03/19 → 30/09/24
Project: Fundamental
-
OZR3022: Bilaterale samenwerking ikv gemeenschappelijk doctoraatsproject: Bench Fee voor Joint PhD VUB-UGent, Schreuer Max
18/05/16 → 30/09/19
Project: Fundamental
-
BOR5: INTERNE OVERDRACHTEN vanuit UZ-Jette (o.a. RIZIV terugbetalingen)
1/10/13 → 31/12/18
Project: Fundamental
-
ANI101: Phase I/II clinical trial on autologous cancer-testis antigen targeted dendritic cell immunotherapy (TriMixDC) for patients with inoperable pretreated colorectal cancer.
Neyns, B., Van Laethem, J. & Van Criekinge, W.
1/01/13 → 31/12/16
Project: Fundamental
-
-
FWOAL640: The development of preclinical models to evaluate combinatorial strategies for augmenting the potency of dendritic cell-based immunotherapy
Neyns, B. & Bonehill, A.
1/01/12 → 31/12/15
Project: Fundamental
-
ANI80: Preclinical investigation of innovative treatment options for melanoma brain metastases.(Onderzoeker Stephanie DU FOUR)
1/10/11 → 30/09/12
Project: Fundamental
-
-
IWTTBM5: Therapeutical vaccination with autologous TriMix dendritic cell vaccine (TriMix-DC) for the treatment of patients with AJCC stage III/IV melanoma.
Neyns, B., Neyns, B., Thielemans, K. & Vermaelen, K.
1/10/09 → 30/09/12
Project: Fundamental
-
ANI61: Predictive factors related to clinical response in patients with metastatic melanoma treated with dendritic cell based immunotherapy.
1/09/09 → 31/08/12
Project: Fundamental
-
-
ANI58: Therapeutic TriMix-dendritic cell vaccination in melanoma patients with and without evaluable disease.
1/01/09 → 31/12/10
Project: Fundamental
-
GOA66: Dendritic cell immunology and dendritic cell based immunotherapy of HIV and cancer.
Thielemans, K., Neyns, B., Velkeniers-Hoebanckx, B. & Lauwers, S.
1/01/09 → 31/12/12
Project: Fundamental